-
LINC01977, Super-Enhancers, and SMAD3 in LUAD
2026-09-15
Zhang et al. identify a super-enhancer-driven LINC01977–SMAD3 circuit that links tumor-associated macrophage signals with malignant behavior in early-stage lung adenocarcinoma. The study combines epigenomic, chromatin-contact, functional, and in vivo evidence, providing a mechanistic framework for investigating canonical TGF-β signaling in tumor progression and related disease models.
-
mRNA Vaccine Protection Against H5N1 in Dairy Cows
2026-09-15
The reference study evaluates a hemagglutinin-based mRNA–lipid nanoparticle vaccine in high-yielding lactating dairy cows, addressing a major translational gap between experimental mRNA platforms and protection in a relevant livestock host. The vaccine was well tolerated, induced strong antibody responses, protected all immunized cattle after a high-dose H5N1 challenge, and retained substantial protection when serum antibody levels had declined.
-
Deferasirox Fe3+ Chelate in Myeloid Research
2026-09-14
This practical guide shows how to use Deferasirox Fe3+ chelate in iron, mitochondrial ROS, and myeloid differentiation workflows. It emphasizes chemical-form controls, oxygen-aware experimental design, and troubleshooting strategies that distinguish ferric-complex effects from free deferasirox activity.
-
Ivermectin Research Workflows for Parasitology
2026-09-14
Build mechanism-first parasite assays with Ivermectin by combining controlled solvent handling, motility readouts, viability measurements, and host-cell counterscreens. This guide also explains how findings from Gasdermin C research can inform assay design without overstating an unproven oncology application.
-
Vorinostat Workflows for HDAC and Apoptosis Research
2026-09-13
Build reproducible HDAC-inhibition experiments with Vorinostat, from concentration–response design to orthogonal apoptosis confirmation. The workflow also shows how the reference study’s live-cell HO-1 activity imaging can support a carefully controlled, hypothesis-generating extension into epigenetic regulation.
-
DAMGO: A Causal Probe of Opioid Pain Biology
2026-09-12
DAMGO is a selective µ-opioid receptor agonist for connecting receptor activation with tissue responses and pain behavior. This article presents an assay-centered framework for interpreting MOR signaling, mechanical hypersensitivity, and tolerance without conflating distinct experimental scales.
-
Antiarrhythmic Drugs and KCa2 Channels in AF
2026-09-12
The reference study systematically tested clinically used antiarrhythmic drugs against human KCa2.2 and KCa2.3 channels using automated whole-cell patch clamp. Dofetilide and propafenone inhibited these channels, whereas the potency gap relative to therapeutic exposure suggests that KCa2 inhibition is unlikely to explain their clinical antiarrhythmic actions.
-
LIRP Enables Light-Controlled Gene Therapy
2026-09-11
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translation-initiation stage. In mouse models, LIRP-regulated AAV2 systems enabled light-dependent metabolic intervention and reversible control of retinal VEGF inhibition, illustrating a potential safety framework for regulated gene therapy.
-
Ivermectin Assay Design: From Dose to Readout
2026-09-11
Ivermectin assay design requires more than selecting a concentration: solvent control, parasite stage, exposure duration, and orthogonal endpoints all shape interpretation. This guide combines rigorous anti-parasitic research practice with assay lessons from a pivotal GSDMC pancreatic cancer study, without overstating cross-domain evidence.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-09-10
This FASEB Journal study presents chemically modified p21 mRNA packaged in lipid nanoparticles for localized intravesical treatment of bladder cancer. The work connects bladder-restricted delivery with tumor-suppressor restoration, cell-cycle inhibition, DNA-damage signaling, and reduced systemic exposure, while also defining important preclinical limitations.
-
Firefly Luciferase mRNA: Reliable Cell Assays
2026-09-10
Learn how EZ Cap™ Firefly Luciferase mRNA (5-moUTP), SKU R1013, can improve reporter-based cell viability, proliferation, and cytotoxicity workflows through defined capping, nucleotide modification, and handling practices. This scenario-driven guide connects transcript design, delivery controls, signal interpretation, and practical product selection.
-
Amplex Red Workflows for H2O2 Assays
2026-09-09
Amplex Red converts hydrogen peroxide into a fluorescent resorufin signal, supporting sensitive enzyme, cell, mitochondrial, and protein-engineering workflows. The reference study shows how an improved peroxidation format can move beyond routine ROS measurement into rapid screening of peroxide-dependent cytochrome P450 variants.
-
Thrombin B Chain Fragment Assay Workflows
2026-09-09
Build more reliable thrombin research workflows with a defined 17-residue B-chain fragment for peptide standards, binding studies, immunoassay controls, and LC-MS method development. Because this reagent is not intact active thrombin, it is especially valuable as a specificity control alongside functional coagulation assays.
-
Septin4, VHL, and HIF-1α in Cardiomyocyte Apoptosis
2026-09-08
The reference study identifies Septin4 as a previously unrecognized regulator of HIF-1α stability in hypoxia-exposed cardiomyocytes. Rather than acting only through its established proapoptotic partners, Septin4 enhances VHL-dependent ubiquitination and degradation of HIF-1α, thereby weakening a cardioprotective hypoxia response and increasing apoptosis.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Assay Reliability
2026-09-08
Learn how EZ Cap™ Cy5 EGFP mRNA (5-moUTP), SKU R1011, separates mRNA uptake from functional translation in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide combines product specifications with published electroporation evidence to improve controls, interpretation, and day-to-day reproducibility.